Mr. Emad Kassabgui graduated from Misr International University (MIU) in 2010 with a B.S. in Pharmaceutical Sciences. Throughout his undergraduate studies, he actively engaged in several internships with prominent organizations such as Servier Ind. and DHL. These invaluable experiences provided him with opportunities to contribute to various projects, which encompassed diverse areas such as pharmaceutical quality control, production, logistics and supply chain departments. After his graduation, Mr. Kassabgui has been heavily involved in the pharmaceutical retail field, in which he prepared and dispensed prescriptions, and counseled thousands of patients over More than 10 years. Since 2021, Mr. Kassabgui decided to shift his career path from retail to drug research development. He joined the “Recognition Health” team as a Clinical Trial Pharmacist and as a Psychometric Rater. He participated in the clinical trials of Alzheimer’s medications “Lecanemab” and “Donanemab” that got approved by the FDA. Mr. Kassabgui Is currently enrolled at Rice University's Professional Science Master's (PSM) Program in Applied Chemistry/Bioorganic and Drug Design, as a major degree. After his master’s, Mr. Kassabgui plans to pursue a Doctor of Pharmacy (PharmD)/ PHD degree.